Related Experiment Video
Updated: May 11, 2026

14:43
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Twenty years of the Cochrane Collaboration
H V Worthington1, A-M Glenny, J E Clarkson
1The University of Manchester, School of Dentistry, Oxford Road, Manchester, M13 9PL, UK. helen.worthington@manchester.ac.uk
Journal of Dental Research
|May 21, 2013
Summary
The Cochrane Collaboration, established in 1993, provides critical health evidence for decision-making. This article highlights the work of the Cochrane Oral Health Group.
Area of Science:
- Health Sciences
- Evidence-Based Medicine
- Public Health
Background:
- The Cochrane Collaboration was founded in 1993.
- It aims to provide a critical evidence base for healthcare decision-making.
- This article focuses on a specific group within the Collaboration.
Purpose of the Study:
- To commemorate the 20th anniversary of The Cochrane Collaboration.
- To illustrate the activities and contributions of the Cochrane Oral Health Group.
- To highlight the importance of evidence synthesis in healthcare.
Main Methods:
- Review of the Cochrane Collaboration's history and mission.
- Description of the organizational structure and focus of the Cochrane Oral Health Group.
- Case study approach to showcase specific work.
Main Results:
- The Cochrane Collaboration has been a significant force in evidence-based healthcare for two decades.
- The Cochrane Oral Health Group plays a vital role in synthesizing research for oral health.
- The group's work supports informed decision-making at multiple levels.
Conclusions:
- The Cochrane Collaboration continues to be a crucial resource for health professionals and policymakers.
- The Cochrane Oral Health Group exemplifies the Collaboration's commitment to providing reliable evidence.
- Continued support for such groups is essential for advancing evidence-based practice in oral health.
Related Concept Videos
Longitudinal Research
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Drug Concentration Versus Time Correlation
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
Cofactors and Coenzymes
Enzymes are proteins made of amino acids. The functional group of each constituent amino acid catalyzes a wide variety of chemical reactions via ionic interactions or acid-base reactions. However, amino acids cannot catalyze oxidation-reduction and group transfer reactions and need to be aided by non-protein components called cofactors. Cofactors are also referred to as the chemical teeth of an enzyme.
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...